secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2021-12-17T23:59:59+00:00
Accession:  0001104659-21-151224
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Director Abbhi retires; shareholders elect board, approve say-on-pay and auditor
--------------------------------------------------------------------------------

- Sankesh Abbhi retired from Board effective Dec. 14, 2021, prior to Annual Meeting; no disagreement.
- All seven director nominees (Arbel, Almenoff, Polverino, Frenkel, Taub, Yablonka, Bairu) elected.
- Non-binding advisory vote on executive compensation passed: 7,594,234 for, 981,374 against.
- Ratification of Brightman Almagor Zohar & Co. as auditor approved: 19,042,561 for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465921151224/0001104659-21-151224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465921151224/tm2135639d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-151224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer